References
- Fleischer AB. Guideline-based medicine grading on the basis of the guidelines of care for ambulatory atopic dermatitis treatment in the United States. J Am Acad Dermatol. 2019;80(2):417–424.
- Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651–663.
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973e33.
- CDC. 2015. NAMCS micro-data file documentation. [cited 2018 Apr 1]. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS
- ICD – ICD-9-CM – International Classification of Diseases, Ninth Revision, Clinical Modification. 2008–2013. Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm#ftp
- Moon SH, Roh HS, Kim YH, et al. Antibiotic resistance of microbial strains isolated from Korean acne patients. J Dermatol. 2012;39(10):833–837.
- Tan J S, Gold L, Schlessinger J, et al. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris. J Drugs Dermatol. 2012; 11(2):174–180.
- Poulin Y, Sanchez NP, Bucko A, et al. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol. 2011;164(6):1376–1382.